← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 3, 2020Last known activity
Jun 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (20)
- NCT06458686Sponsor investigatorPhase 1/Phase 2Jun 30, 2024
- NCT06458686Lead sponsorPhase 1/Phase 2Jun 30, 2024
- NCT05979038Reponsible party - principal investigatorPhase 3Sep 10, 2023
- NCT05979038Lead sponsorPhase 3Sep 10, 2023
- NCT05693597Overall official - principal investigatorPhase 2Jan 24, 2023
- NCT05693597Reponsible party - principal investigatorPhase 2Jan 24, 2023
- NCT05693597Lead sponsorPhase 2Jan 24, 2023
- NCT07242859Lead sponsorN/AJan 15, 2023
- NCT07242859Sponsor investigatorN/AJan 15, 2023
- NCT05641246Lead sponsorPhase 2Dec 8, 2022
- NCT06812585Lead sponsorPhase 2Apr 1, 2022
- NCT06812585Sponsor investigatorPhase 2Apr 1, 2022
- NCT05298670Lead sponsorPhase 2Feb 1, 2022
- NCT05298670Sponsor investigatorPhase 2Feb 1, 2022
- NCT04817904Study chairPhase 2Nov 17, 2020
Details
- Last known activity
- Jun 30, 2024